Skip to main content
. 2015 Sep 18;36(5):197–202. doi: 10.4082/kjfm.2015.36.5.197

Table 2. Tyrosine kinase inhibitors available for treatment of chronic phase chronic myeloid leukemia.

graphic file with name kjfm-36-197-i002.jpg

ALT, alanine aminotransferase.